SlideShare a Scribd company logo
  • Upload
  • Home
  • Explore
  • Login
  • Signup
SlideShare a Scribd company logo
  • Home
  • Explore
  • Upload
  • Login
  • Signup

We've updated our privacy policy. Click here to review the details. Tap here to review the details.

×
×
×
×
×
×
Novosanis

Novosanis

8 Followers
16 SlideShares 0 Clipboards 8 Followers 2 Followings
  • Unblock User Block User
16 SlideShares 0 Clipboards 8 Followers 2 Followings

Personal Information
Organization / Workplace
Antwerp Belgium
Industry
Medical / Health Care / Pharmaceuticals
Website
www.novosanis.com
About
Novosanis is a Belgian, award-winning, innovative developer. ISO13485 certified producer of medical devices adding value to the accuracy of diagnostics tests, drug delivery and overall patient’s comfort. Novosanis is active in the field of infectious diseases and oncology in the areas of prevention, detection and treatment. We have two device platforms in portfolio: VAX-ID™ is a patented and proven platform of injection devices suited for accurate drug delivery in the dermal layer of the skin. Colli-Pee™ is a patented and CE-marked sampling device suited for standardized and guaranteed collection of first-void urine for improved detection of infectious diseases and cancer.
Contact Details
Tags
innovation medical devices medical device vaccine design healthcare vaccination urine sampling intradermal vax-id colli-pee
See more
Documents (16)
See all
Novosanis bio japan2013_jp
9 years ago • 647 Views
Performance of a new first-void urine collection device
7 years ago • 1213 Views
HPV DNA detection in urine: Effect of a first-void urine collection device and time of collection
7 years ago • 1108 Views
The detection of hrHPV-infection of the cervix using first-void urine in women with an abnormal pap-smear
7 years ago • 783 Views
Performance of an Automated HPV Genotyping Assay using First Void Urine Specimens
7 years ago • 1078 Views
High Frequency ultrasound to assess skin thickness in healthy adults to determine maximum penetration depth and needle characteristics
7 years ago • 399 Views
Microbiological evaluation of Medical grade PP in the development of a midstream collector
5 years ago • 76 Views
Computational Modeling for the Design Optimization of a Positive Air Pressure Cleanroom
5 years ago • 116 Views
Colli-Pee: a new device to collect first-void urina at home for molecular detection of STIs
5 years ago • 494 Views
Research into dose sparing potential of VAX-ID
4 years ago • 66 Views
Evaluation of injection forces of VAX-ID to maximize usability, minimize pain & cell death
4 years ago • 98 Views
Shear Stress Test for the Determination of the Optimal Needle Diameter for Injection of Dendritic Cells
4 years ago • 177 Views
Intradermal drug delivery: human, medical and design factors
4 years ago • 239 Views
HF-Ultrasound to assess skin thickness and accuracy of penetration depth of VAX-ID
4 years ago • 76 Views
Assessment of acceptability and usability of new delivery prototype device for intradermal vaccina!on in healthy subjects
4 years ago • 1037 Views
Immunogenicity and Safety of HepatitisB Injection in the Dermis Using VAX-ID
4 years ago • 4624 Views
  • Activity
  • About

Documents (16)
See all
Novosanis bio japan2013_jp
9 years ago • 647 Views
Performance of a new first-void urine collection device
7 years ago • 1213 Views
HPV DNA detection in urine: Effect of a first-void urine collection device and time of collection
7 years ago • 1108 Views
The detection of hrHPV-infection of the cervix using first-void urine in women with an abnormal pap-smear
7 years ago • 783 Views
Performance of an Automated HPV Genotyping Assay using First Void Urine Specimens
7 years ago • 1078 Views
High Frequency ultrasound to assess skin thickness in healthy adults to determine maximum penetration depth and needle characteristics
7 years ago • 399 Views
Microbiological evaluation of Medical grade PP in the development of a midstream collector
5 years ago • 76 Views
Computational Modeling for the Design Optimization of a Positive Air Pressure Cleanroom
5 years ago • 116 Views
Colli-Pee: a new device to collect first-void urina at home for molecular detection of STIs
5 years ago • 494 Views
Research into dose sparing potential of VAX-ID
4 years ago • 66 Views
Evaluation of injection forces of VAX-ID to maximize usability, minimize pain & cell death
4 years ago • 98 Views
Shear Stress Test for the Determination of the Optimal Needle Diameter for Injection of Dendritic Cells
4 years ago • 177 Views
Intradermal drug delivery: human, medical and design factors
4 years ago • 239 Views
HF-Ultrasound to assess skin thickness and accuracy of penetration depth of VAX-ID
4 years ago • 76 Views
Assessment of acceptability and usability of new delivery prototype device for intradermal vaccina!on in healthy subjects
4 years ago • 1037 Views
Immunogenicity and Safety of HepatitisB Injection in the Dermis Using VAX-ID
4 years ago • 4624 Views
Personal Information
Organization / Workplace
Antwerp Belgium
Industry
Medical / Health Care / Pharmaceuticals
Website
www.novosanis.com
About
Novosanis is a Belgian, award-winning, innovative developer. ISO13485 certified producer of medical devices adding value to the accuracy of diagnostics tests, drug delivery and overall patient’s comfort. Novosanis is active in the field of infectious diseases and oncology in the areas of prevention, detection and treatment. We have two device platforms in portfolio: VAX-ID™ is a patented and proven platform of injection devices suited for accurate drug delivery in the dermal layer of the skin. Colli-Pee™ is a patented and CE-marked sampling device suited for standardized and guaranteed collection of first-void urine for improved detection of infectious diseases and cancer.
Contact Details
Tags
innovation medical devices medical device vaccine design healthcare vaccination urine sampling intradermal vax-id colli-pee
See more

Modal header

  • About
  • Support
  • Terms
  • Privacy
  • Copyright
  • Cookie Preferences
  • Do not sell or share my personal information
English
Current Language: English
Español
Português
Français
Deutsch

© 2023 SlideShare from Scribd

We've updated our privacy policy.

We’ve updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.

You can read the details below. By accepting, you agree to the updated privacy policy.

Thank you!

View updated privacy policy
We've encountered a problem, please try again.